USD 13.06
(-1.43%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -24.94 Million | 440.25 Million | 101.21 Million | -107.79 Million | -38.52 Million | 7.34 Million |
Net Income | 5.91 Million | 5.47 Million | 24.61 Million | 12.7 Million | 4.48 Million | -1.2 Million |
Depreciation & Amortization | 2.24 Million | 4.97 Million | 4.74 Million | 5.09 Million | 5.06 Million | 3.51 Million |
Deferred income taxes | 2.11 Million | 424 Thousand | 3.5 Million | -3.7 Million | 595.11 Thousand | -380.2 Thousand |
Stock-based compensation | 631 Thousand | 850 Thousand | 518 Thousand | 416 Thousand | 386.13 Thousand | 238.43 Thousand |
Change in working capital | -6.85 Million | 1.02 Million | -1.18 Million | -4.28 Million | 2.12 Million | 188.02 Thousand |
Other non-cash items | -29 Million | 427.5 Million | 69 Million | -118.04 Million | -51.18 Million | 4.98 Million |
Investing Cash Flow | -161.53 Million | -510.6 Million | 601.86 Million | -933.37 Million | -37.73 Million | -106.93 Million |
Investments in PPE | -7.58 Million | -8.06 Million | -13.29 Million | -3.04 Million | -7.31 Million | -4.78 Million |
Acquisitions | -161.44 Million | - | 659.15 Million | - | - | - |
Investment purchases | -1 Million | -23.89 Million | -33.2 Million | - | - | - |
Sales/Maturities of investments | 6.18 Million | 2.86 Million | 1.68 Million | 1985.00 | 1495.00 | 17.98 Thousand |
Other Investing Activities | 2.31 Million | -481.5 Million | -12.46 Million | -930.33 Million | -30.42 Million | -102.16 Million |
Financing Cash Flow | 178.81 Million | 26.67 Million | -648.72 Million | 985.97 Million | 157.95 Million | 105.39 Million |
Debt repayment | -15.5 Million | -70.1 Million | -818.06 Million | -11.34 Million | -3.93 Million | -20.17 Million |
Dividends payments | -2.27 Million | -2.11 Million | -2.06 Million | -1.77 Million | -1.31 Million | -721.15 Thousand |
Common Stock Repurchased | -13 Thousand | -49 Thousand | 169.55 Million | - | - | - |
Common Stock Issuance | 6.54 Million | 565 Thousand | 1.85 Million | 867.84 Thousand | 5.16 Million | 6.51 Million |
Other Financing Activities | 190.06 Million | 98.95 Million | -6000.00 | 998.22 Million | 158.03 Million | 119.76 Million |
Accounts receivables | -2.67 Million | -920 Thousand | 3.73 Million | -5.17 Million | -375.66 Thousand | -435.52 Thousand |
Accounts payables | 178 Thousand | 378 Thousand | -1.67 Million | 1.77 Million | 72.74 Thousand | -51.15 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | -4.35 Million | 1.56 Million | -3.24 Million | -890.74 Thousand | 2.42 Million | 674.69 Thousand |
Cash at beginning of period | 66.04 Million | 109.72 Million | 55.37 Million | 110.58 Million | 28.88 Million | 23.07 Million |
Cash at end of period | 58.38 Million | 66.04 Million | 109.72 Million | 55.37 Million | 110.58 Million | 28.88 Million |
Capital Expenditure | -7.58 Million | -8.06 Million | -13.29 Million | -3.04 Million | -7.31 Million | -4.78 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -7.66 Million | -43.68 Million | 54.34 Million | -55.2 Million | 81.69 Million | 5.8 Million |
Free Cash Flow | -32.53 Million | 432.18 Million | 87.91 Million | -110.84 Million | -45.83 Million | 2.55 Million |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 876 Thousand | 883 Thousand | 1.66 Million | 5.91 Million | 1.97 Million | 1.41 Million |
Depreciation & Amortization | 629 Thousand | 551 Thousand | 501 Thousand | 2.24 Million | 1.76 Million | 1.64 Million |
Deferred income taxes | 275 Thousand | 288 Thousand | 758 Thousand | 2.11 Million | 644 Thousand | 434 Thousand |
Stock-based compensation | 101 Thousand | 72 Thousand | 172 Thousand | 631 Thousand | 236 Thousand | 131 Thousand |
Change in working capital | -2.22 Million | -3.51 Million | -1.35 Million | -6.85 Million | 537 Thousand | 492 Thousand |
Other non-cash items | 80.44 Million | 126.37 Million | -7.77 Million | -29 Million | 129.91 Million | 123.15 Million |
Investing Cash Flow | -149.72 Million | -150.71 Million | -29.22 Million | -161.53 Million | -170.45 Million | -171.2 Million |
Investments in PPE | -390 Thousand | -1 Million | -1.38 Million | -7.58 Million | -460 Thousand | -2.86 Million |
Acquisitions | - | - | -27.78 Million | -161.44 Million | -2.19 Million | - |
Investment purchases | -1.22 Million | -4.45 Million | -1 Million | -1 Million | 1.08 Million | -1.29 Million |
Sales/Maturities of investments | 3.9 Million | 1.21 Million | -1.36 Million | 6.18 Million | 1.11 Million | 994 Thousand |
Other Investing Activities | -771 Thousand | -458 Thousand | 2.31 Million | 2.31 Million | -169.99 Million | -168.03 Million |
Financing Cash Flow | 74.23 Million | 26.29 Million | -18.69 Million | 178.81 Million | 44.23 Million | 15.97 Million |
Debt repayment | -39.88 Million | -4.88 Million | -9.88 Million | -15.5 Million | -25.11 Million | -164 Thousand |
Dividends payments | -716 Thousand | -716 Thousand | -669 Thousand | -2.27 Million | -536 Thousand | -537 Thousand |
Common Stock Repurchased | -13 Thousand | -7000.00 | 329 Thousand | -13 Thousand | -3000.00 | -10 Thousand |
Common Stock Issuance | 7000.00 | -51 Thousand | 4.41 Million | 6.54 Million | 41 Thousand | 129 Thousand |
Other Financing Activities | 35.07 Million | 27.12 Million | -32.65 Million | 190.06 Million | 69.84 Million | 16.55 Million |
Accounts receivables | -375 Thousand | -495 Thousand | -223 Thousand | -2.67 Million | -978 Thousand | -382 Thousand |
Accounts payables | -426 Thousand | 716 Thousand | 250 Thousand | 178 Thousand | 60 Thousand | -288 Thousand |
Inventory | - | - | - | - | - | - |
Other working capital | -2.22 Million | -3.02 Million | -1.38 Million | -4.35 Million | 1.45 Million | 1.16 Million |
Cash at beginning of period | 57.5 Million | 58.38 Million | 112.55 Million | 66.04 Million | 103.7 Million | 131.66 Million |
Cash at end of period | 60.77 Million | 57.5 Million | 58.38 Million | 58.38 Million | 112.55 Million | 103.7 Million |
Capital Expenditure | -390 Thousand | -1 Million | -1.38 Million | -7.58 Million | -460 Thousand | -2.86 Million |
Effect of forex changes on cash | - | - | -207 Thousand | - | - | - |
Net cash flow / Change in cash | 3.26 Million | -880 Thousand | -54.16 Million | -7.66 Million | 8.84 Million | -27.96 Million |
Free Cash Flow | 78.35 Million | 122.47 Million | -7.42 Million | -32.53 Million | 134.6 Million | 124.4 Million |
PHARMAID
FUAPF
DXYZ
UNIINFO
PSYTF
300056